Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting opioid antagonist treatment for opioid-dependent patients: effects on substance use and criminality
2009-012461-54Phase 4Active
- Sponsor
- Region Sörmland
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of naltrexone in opioid use disorder (OUD), sponsored by Region Sörmland. Primary endpoint: Recruitment and follow-up phases. Started Apr 2010; status: active.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2009-012461-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012461-54.